Avidity Biosciences (RNA) Receivables - Other (2024 - 2025)
Avidity Biosciences (RNA) has disclosed Receivables - Other for 2 consecutive years, with $12.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 31.67% year-over-year to $12.4 million, compared with a TTM value of $12.4 million through Dec 2025, up 31.67%, and an annual FY2025 reading of $12.4 million, up 31.67% over the prior year.
- Receivables - Other was $12.4 million for Q4 2025 at Avidity Biosciences, down from $15.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $15.0 million in Q3 2025 and bottomed at $8.5 million in Q2 2025.